These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7696730)
1. Beta-agonists in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Kuhl DA; Agiri OA; Mauro LS Ann Pharmacother; 1994 Dec; 28(12):1379-88. PubMed ID: 7696730 [TBL] [Abstract][Full Text] [Related]
2. Metered-dose inhalers and nebulizers in the acute setting. Kisch GL; Paloucek FP Ann Pharmacother; 1992 Jan; 26(1):92-5. PubMed ID: 1351411 [TBL] [Abstract][Full Text] [Related]
3. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group. Chest; 1994 May; 105(5):1411-9. PubMed ID: 8181328 [TBL] [Abstract][Full Text] [Related]
4. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Rodrigo GJ; Rodrigo C Am J Respir Crit Care Med; 2000 Jun; 161(6):1862-8. PubMed ID: 10852758 [TBL] [Abstract][Full Text] [Related]
6. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients. Pillet O; Manier G; Castaing Y Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900 [TBL] [Abstract][Full Text] [Related]
7. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence. Blais L; Forget A; Ramachandran S Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems. Staggs L; Peek M; Southard G; Gracely E; Baxendale S; Cross KP; Kim IK J Med Econ; 2012; 15(4):704-11. PubMed ID: 22400716 [TBL] [Abstract][Full Text] [Related]
9. Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial. Beier J; Chanez P; Martinot JB; Schreurs AJ; Tkácová R; Bao W; Jack D; Higgins M Pulm Pharmacol Ther; 2007; 20(6):740-9. PubMed ID: 17088091 [TBL] [Abstract][Full Text] [Related]
10. Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. Chou KJ; Cunningham SJ; Crain EF Arch Pediatr Adolesc Med; 1995 Feb; 149(2):201-5. PubMed ID: 7849885 [TBL] [Abstract][Full Text] [Related]
12. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response. Duarte AG; Momii K; Bidani A Respir Care; 2000 Jul; 45(7):817-23. PubMed ID: 10926377 [TBL] [Abstract][Full Text] [Related]
13. Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to beta-agonist therapy. Shrestha M; O'Brien T; Haddox R; Gourlay HS; Reed G Ann Emerg Med; 1991 Nov; 20(11):1206-9. PubMed ID: 1835324 [TBL] [Abstract][Full Text] [Related]
14. Beta-adrenergic agonists for acute, severe asthma. Kelly HW; Murphy S Ann Pharmacother; 1992 Jan; 26(1):81-91. PubMed ID: 1351410 [TBL] [Abstract][Full Text] [Related]
15. An evaluation of nebulized levalbuterol in stable COPD. Datta D; Vitale A; Lahiri B; ZuWallack R Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007 [TBL] [Abstract][Full Text] [Related]